Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.

Literature DB >> 25573910

Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.

Christopher P Larsen¹, Barry I Freedman².

Abstract

Entities: Disease Gene

Keywords: APOL1; FSGS; HIV nephropathy; collapsing FSGS; collapsing glomerulopathy; genetic; idiopathic nephrotic syndrome; renal disease

Mesh：

Substances：

Year: 2015 PMID： 25573910 PMCID： PMC4446887 DOI： 10.1681/ASN.2014101052

Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121

× No keyword cloud information.

16 in total

1. Pathologic classification of focal segmental glomerulosclerosis: a working proposal.

Authors: Vivette D D'Agati; Agnes B Fogo; Jan A Bruijn; J Charles Jennette
Journal: Am J Kidney Dis Date: 2004-02 Impact factor: 8.860

2. Association of trypanolytic ApoL1 variants with kidney disease in African Americans.

Authors: Giulio Genovese; David J Friedman; Michael D Ross; Laurence Lecordier; Pierrick Uzureau; Barry I Freedman; Donald W Bowden; Carl D Langefeld; Taras K Oleksyk; Andrea L Uscinski Knob; Andrea J Bernhardy; Pamela J Hicks; George W Nelson; Benoit Vanhollebeke; Cheryl A Winkler; Jeffrey B Kopp; Etienne Pays; Martin R Pollak
Journal: Science Date: 2010-07-15 Impact factor: 47.728

3. Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression.

Authors: Sabrina Giglio; Aldesia Provenzano; Benedetta Mazzinghi; Francesca Becherucci; Laura Giunti; Giulia Sansavini; Fiammetta Ravaglia; Rosa Maria Roperto; Silvia Farsetti; Elisa Benetti; Mario Rotondi; Luisa Murer; Elena Lazzeri; Laura Lasagni; Marco Materassi; Paola Romagnani
Journal: J Am Soc Nephrol Date: 2014-07-24 Impact factor: 10.121

4. The APOL1 gene and allograft survival after kidney transplantation.

Authors: A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal: Am J Transplant Date: 2011-04-12 Impact factor: 8.086

Review 5. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors: Barry I Freedman; Karl Skorecki
Journal: Clin J Am Soc Nephrol Date: 2014-06-05 Impact factor: 8.237

6. Clinical Features and Histology of Apolipoprotein L1-Associated Nephropathy in the FSGS Clinical Trial.

Authors: Jeffrey B Kopp; Cheryl A Winkler; Xiongce Zhao; Milena K Radeva; Jennifer J Gassman; Vivette D D'Agati; Cynthia C Nast; Changli Wei; Jochen Reiser; Lisa M Guay-Woodford; Martin R Pollak; Friedhelm Hildebrandt; Marva Moxey-Mims; Debbie S Gipson; Howard Trachtman; Aaron L Friedman; Frederick J Kaskel
Journal: J Am Soc Nephrol Date: 2015-01-08 Impact factor: 10.121

7. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.

Authors: Christopher P Larsen; Marjorie L Beggs; Mohammad Saeed; Josephine M Ambruzs; L Nicholas Cossey; Nidia C Messias; Patrick D Walker; Barry I Freedman
Journal: Mod Pathol Date: 2014-08-01 Impact factor: 7.842

8. HIV-associated nephropathy patients with and without apolipoprotein L1 gene variants have similar clinical and pathological characteristics.

Authors: Mohamed G Atta; Michelle M Estrella; Michael Kuperman; Matthew C Foy; Derek M Fine; Lorraine C Racusen; Gregory M Lucas; George W Nelson; Andrew C Warner; Cheryl A Winkler; Jeffrey B Kopp
Journal: Kidney Int Date: 2012-04-11 Impact factor: 10.612

9. APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.

Authors: Duncan B Johnstone; Vijay Shegokar; Deepak Nihalani; Yogendra Singh Rathore; Leena Mallik; Vasant Zare; H Omer Ikizler; Rajaram Powar; Lawrence B Holzman
Journal: PLoS One Date: 2012-12-26 Impact factor: 3.240

10. Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1.

Authors: Brendan Nichols; Prachi Jog; Jessica H Lee; Daniel Blackler; Michael Wilmot; Vivette D'Agati; Glen Markowitz; Jeffrey B Kopp; Seth L Alper; Martin R Pollak; David J Friedman
Journal: Kidney Int Date: 2014-08-06 Impact factor: 10.612

9 in total

Review 1. APOL1: The Balance Imposed by Infection, Selection, and Kidney Disease.

Authors: Pazit Beckerman; Katalin Susztak
Journal: Trends Mol Med Date: 2018-06-07 Impact factor: 11.951

2. Strict blood pressure control associates with decreased mortality risk by APOL1 genotype.

Authors: Elaine Ku; Michael S Lipkowitz; Lawrence J Appel; Afshin Parsa; Jennifer Gassman; David V Glidden; Miroslaw Smogorzewski; Chi-Yuan Hsu
Journal: Kidney Int Date: 2016-12-04 Impact factor: 10.612

3. Lupus Podocytopathy: A Distinct Entity.

Authors: Andrew S Bomback; Glen S Markowitz
Journal: Clin J Am Soc Nephrol Date: 2016-03-16 Impact factor: 8.237

4. Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndrome.

Authors: Laurène Dehoux; Julien Hogan; Claire Dossier; Marc Fila; Olivier Niel; Anne Maisin; Marie Alice Macher; Thérésa Kwon; Véronique Baudouin; Georges Deschênes
Journal: Pediatr Nephrol Date: 2016-06-04 Impact factor: 3.714

5. ApoL1 levels in high density lipoprotein and cardiovascular event presentation in patients with familial hypercholesterolemia.

Authors: Judit Cubedo; Teresa Padró; Rodrigo Alonso; Pedro Mata; Lina Badimon
Journal: J Lipid Res Date: 2016-04-25 Impact factor: 5.922

6. Role of Apolipoprotein L1 in Human Parietal Epithelial Cell Transition.

Authors: Vinod Kumar; Himanshu Vashistha; Xiqian Lan; Nirupama Chandel; Kamesh Ayasolla; Seyedeh Shadafarin Marashi Shoshtari; Rukhsana Aslam; Nitpriya Paliwal; Frank Abbruscato; Joanna Mikulak; Waldemar Popik; Mohamed G Atta; Praveen N Chander; Ashwani Malhotra; Catherine Meyer-Schwesinger; Karl Skorecki; Pravin C Singhal
Journal: Am J Pathol Date: 2018-09-08 Impact factor: 4.307